2nd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    June 8-9, 2022

Confirmed Speakers

PL05 - Affinity Selection Mass Spectrometry (ASMS) for Experimental Target Tractability Assessment (eTA)

Dr Lauren KUSTIGIAN
Dr Lauren KUSTIGIAN
GSK, Collegeville, PA, United States
Read more

PL02 - Challenges and Opportunities in the Application of Affinity Selection Mass Spectrometry in Early Drug Discovery

Dr Manuel Francisco MOLINA-MARTIN
Dr Manuel Francisco MOLINA-MARTIN
LILLY LABORATORIES, Madrid, Spain
Read more

PL01 - Using Affinity-selection MS to Find Compounds that Disrupt RNA Structure and X-Chromosome Inactivation via Xist

Dr Elliott B. NICKBARG
Dr Elliott B. NICKBARG
MERCK RESEARCH LABORATORIES, Boston, United States
Read more

PL04 - Affinity Selection-Mass Spectrometry for Oligonucleotides, Proteins, Cells, and Animals

Prof. Bradley Lether PENTELUTE
Prof. Bradley Lether PENTELUTE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA, United States
Read more

PL03 - Utilizing Mass Spectrometry to Discover RNA-binding Small Molecules

Dr Scott RUSIN
Dr Scott RUSIN
ARRAKIS THERAPEUTICS, Waltham, MA, United States
Read more

PL06 - Difficulties and Solutions Along the ASMS Data Analysis Pathway

Dr Mark SPEARS
Dr Mark SPEARS
VIRSCIDIAN, Cary, NC, United States
Read more